Axa’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Axa’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-80,427	Closed	-$4.3M	–	1474
2016 Q1	$4.3M	Sell	80,427 -64,457	-44%	-$4.76M	0.02%	597
2015 Q4	$16.4M	Buy	144,884 +53,254	+58%	+$5.87M	0.07%	275
2015 Q3	$10.8M	Buy	+91,630	New	+$12M	0.04%	364
2014 Q3	–	Sell	-238,735	Closed	-$4.23M	–	1542
2014 Q2	$4.23M	Sell	238,735 -9,603	-4%	-$155K	0.02%	592
2014 Q1	$4.97M	Buy	248,338 +80,166	+48%	+$1.55M	0.02%	522
2013 Q4	$2.82M	Buy	+168,172	New	+$2.33M	0.01%	689

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Axa's ANAC Position: Q2 2016 in Review

Axa sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 80,427 shares — an estimated $4.3M sold.

Axa first reported a position in ANAC in Q4 2013 and held it in 6 quarters. The position peaked at $16.4M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Axa reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Axa sold 80,427 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $4.3M.
Axa first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2013 and held it in 6 quarters.
Axa's ANACOR PHARMACEUTICALS INC COM position peaked at $16.4M in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Axa's 13F filing for Q2 2016, filed 11 Aug 2016.